Conversely, metformin administration attenuated the olanzapine-induced upregulation of PCSK9, FAS, and SCD1 as well as downregulation of SCAD and PPARα, effectively improving hepatic/hepatocyte steatosis. The gene discussed is PCSK9; the disease is steatosis.